Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-12

Clinical Trial Update: Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating a combination therapy of doxycycline, pentoxifylline, and nitazoxanide for sexually transmitted diseases is listed as not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)
  • Nitazoxanide (nitazoxanide)
  • Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Tanta University | Conditions: Sexually Transmitted Diseases | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING